Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) accounts for the highest proportion of lung cancers; however, specific biomarkers are lacking for diagnosis, treatment, and prognostic assessment. Cell division cycle-associated 8 (CDCA8) is a cell cycle regulator with elevated expression in various can...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-11-01
|
| Col·lecció: | BMC Medical Genomics |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12920-024-02019-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|